Ann Marie Rossi
Biohaven Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Microtubule and mitosis dynamics, HER2/EGFR in Cancer Research, Cancer, Hypoxia, and Metabolism, Immune Cell Function and Interaction
Most-Cited Works
- → PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer(2016)815 cited
- → Combination Therapy Enhances the Inhibition of Tumor Growth with the Fully Human Anti–Type 1 Insulin-Like Growth Factor Receptor Monoclonal Antibody CP-751,871(2005)361 cited
- → Discovery of GS-9973, a Selective and Orally Efficacious Inhibitor of Spleen Tyrosine Kinase(2014)168 cited
- Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy.(2003)
- → Design and SAR of thienopyrimidine and thienopyridine inhibitors of VEGFR-2 kinase activity(2003)96 cited
- → PF-03814735, an Orally Bioavailable Small Molecule Aurora Kinase Inhibitor for Cancer Therapy(2010)87 cited
- → Discovery and Pharmacologic Characterization of CP-724,714, a Selective ErbB2 Tyrosine Kinase Inhibitor(2007)76 cited
- The biological and biochemical effects of CP-654577, a selective erbB2 kinase inhibitor, on human breast cancer cells.(2003)
- → Adjunctive intracardiac echocardiography imaging from the left ventricle to guide percutaneous mitral valve repair with the mitraclip in patients with failed prior surgical rings(2015)24 cited
- → Process improvements and shared medical appointments for cardiovascular disease prevention in women(2013)10 cited